参考文献/References:
[1] WONG T Y,CHEUNG C M G,LARSEN M,SHARMA S,SIMO R.Diabetic retinopathy [J].Nat Rev Dis Primers,2016,2:16012.
[2] KEICK T W,BRESSLER N M.Recent clinically relevant highlights from the diabetic retinopathy clinical research network [J].Curr Opin Ophthalmol,2018,29 (3):199-205.
[3] MANSOUR S E,BROWING D J,WONG K,FLYNN H W Jr,BHAVSAR A R.The evolving treatment of diabetic retinopathy [J].Clin Ophthalmol,2020,14:653-678.
[4] CHAKRAVARTHY H,DEVANATHAN V.Molecular mechanisms mediating diabetic retinal neurodegeneration:potential research avenues and therapeutic targets [J].J Mol Neurosci,2018,66(3):445-461.
[5] BOON R A,JAE N,HOLDT L.Long noncoding RNAs:from clinical genetics to therapeutic targets ? [J].J Am Coll Cardiol,2016,67(10):1214-1226.
[6] LAPIERRE M P,STOFFEL M.MicroRNAs as stress regulators in pancreatic beta cells and diabetes [J].Mol Metab,2017,6(9):1010-1023.
[7] GONG Q,SU G.Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy [J].Biosci Rep,2017,37(6):BSR20171157.
[8] YAN B,TAO Z F,LI X M,ZHANG H,YAO J,JIANG Q.Aberrant expression of long noncoding RNAs in early diabetic retinopathy [J].Invest Ophthalmol Vis Sci,2014,55(2):941-951.
[9] TORAIH E A,ABDELGHANY A A,FADEAL N M A,AGEELI E A,FAWZY M S.Deciphering the role of circulating lncRNAs:RNCR2,NEAT2,CDKN2B-AS1,and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients [J].Graefes Arch Clin Exp Ophthalmol,2019,257(9):1897-1913.
[10] QIU G Z,TIAN W,FU H T,LI C P,LIU B.Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction [J].Biochem Bioph Res Commun,2016,471:135-141.
[11] ZHANG Y,LIU X,BAI X,LIN Y,LI Z,FU J B,et al.Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis [J].J Pineal Res,2018,64:e12449.
[12] SHAO J,FAN G M,YIN X W,GU Y,WANG X L,XIN Y,et al.A novel transthyretin /STAT4 /miR-223-3p /FBXW7 signaling pathway affects neovascularization in diabetic retinopathy [J].Mol Cell Endocrinol,2019,498:110541.
[13] SABANAYAGAM C,BAMU R,CHEE M L,LEE R,WANG Y X,TAN G,et al.Incidence and progression of diabetic retinopathy:A systematic review [J].Lancet Diabetes Endocrinol,2019,7(2):140-149.
[14] WU Z,LIU X,LIU L,DENG H L,ZHANG J J,XU Q,et al.Regulation of lncRNA expression [J].Cell Mol Biol Lett,2014,19(4):561-575.
[15] XIE Q X,LIN S N,ZHENG M J,CAI Q T,TU Y.Long noncoding RNA NEAT1 promoted the growth of cervical cancer cells via sponging miR-9-5p [J].Biochem Cell Biol,2019,97(2):100-108.
[16] MICHALIK K M,YOU X,MANAVSKI Y,DODDABALLAPUR A, ZRNIG M,BRAUN T,et al.Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth [J].Circ Res,2014,114(9):1389-1397.
[17] XIAO W,CHEN X,HE M.Inhibition of the jagged/notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt,Src,p38MAPK and Wnt/β-catenin signaling pathways [J].Mol Med Rep,2014,10(1):453-458.
[18] ZHANG H,SHENG C,YIN Y,WEN S,YANG G P,CHENG Z N,et al.PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma [J].Cancer Lett,2015,367(1):49-57.
[19] STUPFLER B,BIRCK C,SRAPHIN B,MAUXION B.BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation [J].Nat Commun,2016,7:10811.
[20] PENG Y Z,YUAN J J,ZHANG Z C,CHANG X.Cytoplasmic poly(A)-binding protein 1 (PABPC1) interacts with the RNA-binding protein hnRNPLL and thereby regulates immunoglobulin secretion in plasma cells [J].J Biol Chem,2017,292 (29):12285-12295.
相似文献/References:
[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]郎海波,黄敏丽.长链非编码RNA在糖尿病视网膜病变发展及治疗中的研究进展[J].眼科新进展,2019,39(5):482.[doi:10.13389/j.cnki.rao.2019.0111]
LANG Hai-Bo,HUANG Min-Li.Research progress of lncRNA in the development and treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2019,39(7):482.[doi:10.13389/j.cnki.rao.2019.0111]
[12]王中原,孙劲禹,谢田华,等.长链非编码RNA在糖尿病视网膜病变发病机制中的作用[J].眼科新进展,2020,40(5):487.[doi:10.13389/j.cnki.rao.2020.0112]
WANG Zhongyuan,SUN Jinyu,XIE Tianhua,et al.Research progress on role of lncRNA in diabetic retinopathy[J].Recent Advances in Ophthalmology,2020,40(7):487.[doi:10.13389/j.cnki.rao.2020.0112]
[13]邱煜焱,杨旭,苟文军,等.2型糖尿病患者血清lncRNA MALAT1表达水平与视网膜病变的关系[J].眼科新进展,2022,42(12):971.[doi:10.13389/j.cnki.rao.2022.0199]
QIU Yuyan,YANG Xu,GOU Wenjun,et al.Relationship between the expression level of long non-coding ribonucleic acid metastasis associated lung adenocarcinoma transcript 1 in serum and retinopathy in patients with type 2 diabetes mellitus[J].Recent Advances in Ophthalmology,2022,42(7):971.[doi:10.13389/j.cnki.rao.2022.0199]
[14]王艳平,刘含军.长链非编码RNA(LncRNA)母系表达基因3(MEG3)对糖尿病视网膜病变大鼠模型视网膜血管内皮细胞凋亡的影响[J].眼科新进展,2023,43(1):018.[doi:10.13389/j.cnki.rao.2023.0004]
WANG Yanping,LIU Hanjun.Effect of long non-coding ribonucleic acid maternally expressed gene 3 on retinal vascular endothelial cell apoptosis in rats with diabetes retinopathy[J].Recent Advances in Ophthalmology,2023,43(7):018.[doi:10.13389/j.cnki.rao.2023.0004]